Rationale and design of the national benchmarking and evidence-based national clinical guidelines for chronic heart failure management programs study

Driscoll, Andrea, Worrall-Carter, Linda and Stewart, Simon 2006, Rationale and design of the national benchmarking and evidence-based national clinical guidelines for chronic heart failure management programs study, Journal of cardiovascular nursing, vol. 21, no. 4, pp. 276-282.

Attached Files
Name Description MIMEType Size Downloads

Title Rationale and design of the national benchmarking and evidence-based national clinical guidelines for chronic heart failure management programs study
Author(s) Driscoll, AndreaORCID iD for Driscoll, Andrea orcid.org/0000-0002-6837-0249
Worrall-Carter, Linda
Stewart, Simon
Journal name Journal of cardiovascular nursing
Volume number 21
Issue number 4
Start page 276
End page 282
Publisher Lippincott Williams & Wilkins
Place of publication Gaithersburg, Md.
Publication date 2006-07
ISSN 0889-4655
Keyword(s) benchmarks
chronic disease management programs
chronic heart failure
clinical audit
postdischarge programs
Summary OBJECTIVES: The National Benchmarks and Evidence-Based National Clinical Guidelines for Heart Failure Management Programs Study is a national, multicenter study designed to determine the nature, range, and effect of interventions applied by chronic heart failure management programs (CHF-MPs) throughout Australia on patient outcomes. Its primary objective is to use these data to develop national benchmarks and evidence-based clinical guidelines and optimize their cost-effective application by reducing quality and outcome variability. DATA SOURCES/STUDY SETTING: Primary data will be collected from CHF-MP coordinators and CHF patients enrolled in these programs on a national basis. Secondary outcome data will be collected from a national morbidity record and from patients' medical records. STUDY DESIGN: Stage I of the study involves a prospective clinical audit of all CHF-MPs throughout Australia (n = 45) to determine the extent of variability in programs currently. Stage II is a prospective cross-sectional survey design enrolling 1,500 patients (average of 40 patients per program) to firstly determine the typical profile of patients being managed via a CHF-MP in Australia and, secondly, the subsequent morbidity and mortality during the 6-month follow-up. Outcome data will be subject to multivariate analysis to determine the key components of care in this regard. All study data will be then examined in the final stage of the study (III) to develop national benchmarks for the application and auditing of CHF-MPs in Australia. CONCLUSION: Variability in patient outcomes is a product of heterogeneity among CHF-MPs. The development of national benchmarks will minimize such heterogeneity and will provide a greater level of evidence for their cost-effective application.
Language eng
Field of Research 110201 Cardiology (incl Cardiovascular Diseases)
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2006, Lippincott Williams & Wilkins
Persistent URL http://hdl.handle.net/10536/DRO/DU:30003971

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 15 times in TR Web of Science
Scopus Citation Count Cited 17 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 863 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Mon, 07 Jul 2008, 09:08:27 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.